Caricamento...
PPARγ is dispensable for clear cell renal cell carcinoma progression
OBJECTIVE: Clear cell renal cell carcinoma (ccRCC) is a subtype of kidney cancer defined by robust lipid accumulation, which prior studies have indicated plays an important role in tumor progression. We hypothesized that the peroxisome proliferator-activated receptor gamma (PPARγ), detected in both...
Salvato in:
| Pubblicato in: | Mol Metab |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6034040/ https://ncbi.nlm.nih.gov/pubmed/29866440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2018.05.013 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|